Abstract
Clinical trials face persistent challenges in cost, enrollment, and generalizability. This perspective examines how artificial intelligence (AI), large language models (LLMs), adaptive trial designs, and digital twins (DTs) can modernize trial design and execution. We detail AI-driven eligibility optimization, reinforcement learning for real-time adaptation, and in silico DT modeling. Methodological, regulatory, and ethical hurdles are addressed, emphasizing the need for validated, scalable frameworks to enable responsible and widespread integration.
| Original language | English (US) |
|---|---|
| Article number | 683 |
| Journal | npj Digital Medicine |
| Volume | 8 |
| Issue number | 1 |
| DOIs |
|
| State | Published - Dec 2025 |
All Science Journal Classification (ASJC) codes
- Medicine (miscellaneous)
- Health Informatics
- Computer Science Applications
- Health Information Management